These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors. Patel RR; Ramkissoon SH; Ross J; Weintraub L Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112 [TBL] [Abstract][Full Text] [Related]
24. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology. Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249 [TBL] [Abstract][Full Text] [Related]
26. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae. Plant-Fox AS; O'Halloran K; Goldman S Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558 [TBL] [Abstract][Full Text] [Related]
27. RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations. Jeuken J; van den Broecke C; Gijsen S; Boots-Sprenger S; Wesseling P Acta Neuropathol; 2007 Aug; 114(2):121-33. PubMed ID: 17588166 [TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review. Nobusawa S; Hirato J; Yokoo H Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241 [TBL] [Abstract][Full Text] [Related]
32. Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas. Kambhampati M; Panditharatna E; Yadavilli S; Saoud K; Lee S; Eze A; Almira-Suarez MI; Hancock L; Bonner ER; Gittens J; Stampar M; Gaonkar K; Resnick AC; Kline C; Ho CY; Waanders AJ; Georgescu MM; Rance NE; Kim Y; Johnson C; Rood BR; Kilburn LB; Hwang EI; Mueller S; Packer RJ; Bornhorst M; Nazarian J Sci Rep; 2020 Jul; 10(1):10954. PubMed ID: 32616776 [TBL] [Abstract][Full Text] [Related]
33. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series. Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405 [TBL] [Abstract][Full Text] [Related]
34. Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study. Lassaletta A; Scheinemann K; Zelcer SM; Hukin J; Wilson BA; Jabado N; Carret AS; Lafay-Cousin L; Larouche V; Hawkins CE; Pond GR; Poskitt K; Keene D; Johnston DL; Eisenstat DD; Krishnatry R; Mistry M; Arnoldo A; Ramaswamy V; Huang A; Bartels U; Tabori U; Bouffet E J Clin Oncol; 2016 Oct; 34(29):3537-3543. PubMed ID: 27573663 [TBL] [Abstract][Full Text] [Related]
35. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status. Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668 [TBL] [Abstract][Full Text] [Related]
36. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors. Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289 [TBL] [Abstract][Full Text] [Related]
38. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis. Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612 [TBL] [Abstract][Full Text] [Related]